Schedule 13D ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Security class unavailable · CUSIP: 09058V103
Event date: 2016-08-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,038,944
- Percent of class
- 14.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-119837
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Aug 16, 2016
- Reporting period
- Aug 12, 2016
- Description
- Schedule 13D beneficial ownership